The Weinberg Group, a ProPharma Group company, is the global leader in regulatory and compliance services, with headquarters in Washington, D.C. For over 35 years, we have provided biotech, medical device, and pharmaceutical consulting services to companies of every size on every continent, supplying them with viable and efficient drug development pathways and compliance solutions.
The Weinberg Group was acquired by ProPharma Group on January 25, 2019. By joining forces, we expand our current service portfolio of pre-approval/pre-clinical regulatory service solutions to also now include post-approval regulatory services, establishing an end-to-end global solution for our clients. Our service footprint now allows us to service clients at all stages of drug, device and biotechnology development, and in any geographic region.
|
|
|
11-50 employees
View all The Weinberg Group employees
|
|
Pharmaceuticals
|
|
1129 Twentieth St., NW, Suite 600, Washington, DC 20036, US
|
|
1983
|
|
Biotech, Consulting, Medical Devices, Pharmaceuticals, Diagnostics, Clinical Pharmacology, Biologics, Ivds, Quality Assurance/Control, Gmp Compliance, Gcp Compliance, Glp Compliance, Regulatory Affairs/Regulatory Strategy, Regulatory Document Preparation
|
Matthew Weinberg is the CEO of The Weinberg Group. To contact Matthew Weinberg email at [email protected].
The decision makers in The Weinberg Group are Bob Roth, Eleanor Perfetto, Joel Falk, etc. Click to Find The Weinberg Group decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.